Walleye Trading
RVNC

Walleye Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Walleye Trading’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,078
Closed -$79.1K – 5058
2024
Q1 		$79.1K Sell
16,078
-26,694
-62% -$158K ﹤0.01% 3862
2023
Q4 		$376K Buy
42,772
+30,190
+240% +$247K ﹤0.01% 3313
2023
Q3 		$144K Buy
12,582
+12,475
+11,659% +$240K ﹤0.01% 3798
2023
Q2 		$2.71K Sell
107
-13,345
-99% -$416K ﹤0.01% 4448
2023
Q1 		$433K Sell
13,452
-14,631
-52% -$456K ﹤0.01% 2921
2022
Q4 		$518K Sell
28,083
-77,605
-73% -$1.78M ﹤0.01% 2785
2022
Q3 		$2.85M Buy
105,688
+68,890
+187% +$1.4M 0.01% 1429
2022
Q2 		$509K Sell
36,798
-60,402
-62% -$930K ﹤0.01% 2903
2022
Q1 		$1.9M Buy
97,200
+84,480
+664% +$1.28M 0.01% 1708
2021
Q4 		$208K Buy
+12,720
New +$212K ﹤0.01% 3829
2021
Q3 		– Sell
-9,991
Closed -$285K – 5820
2021
Q2 		$296K Buy
+9,991
New +$288K ﹤0.01% 3522
2018
Q4 		– Sell
-21,501
Closed -$534K – 5436
2018
Q3 		$534K Buy
21,501
+6,562
+44% +$178K ﹤0.01% 2823
2018
Q2 		$410K Buy
+14,939
New +$449K ﹤0.01% 3019
2016
Q1 		– Sell
-4
Closed – – 5944
2015
Q4 		$0 Buy
+4
New +$139 ﹤0.01% 5769
2015
Q3 		– Sell
-300
Closed -$10K – 5610
2015
Q2 		$10K Buy
+300
New +$7.71K ﹤0.01% 4313

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's RVNC Position: Q2 2024 in Review

Walleye Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2024, closing a stake of 16,078 shares — an estimated $79.1K sold.

Walleye Trading first reported a position in RVNC in Q2 2015 and held it in 15 quarters. The position peaked at $2.85M in Q3 2022. 173 funds tracked by Wall St. Rank hold RVNC as of Q2 2024.

  • Walleye Trading reported no remaining Revance Therapeutics, Inc. position as of Q2 2024 after selling out during the quarter.
  • Walleye Trading sold 16,078 Revance Therapeutics, Inc. shares in Q2 2024, an estimated $79.1K.
  • Walleye Trading first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 15 quarters.
  • Walleye Trading's Revance Therapeutics, Inc. position peaked at $2.85M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2024.

Based on Walleye Trading's 13F filing for Q2 2024, filed 14 Aug 2024.